Zyprexa news | Breaking Zyprexa news | Zyprexa

US study affirms effectiveness of schizophrenia drug

...Joseph McEvoy of the Duke University Medical Center.

That's not a surprise, he said, because Clozaril "was believed to be the most therapeutically effective drug out there." But it's under-used because of the risk of side effects that require patients to go through special monitoring, he said.

In a companion analysis of other patients who did not want to try Clozaril or who'd abandoned their first medication because of side effects, Risperdal and Clozaril is sold by Novartis SA, Risperdal by Janssen Pharmaceutica and Both papers appear in the April issue of the American Journal of Psychiatry.

The work, funded by the National Institute of Mental Health, was the second phase of a government study to seek the most effective way to treat people with this devastating mental disorder.

Schizophrenics struggle with such symptoms as hallucinations, delusions, social withdrawal, and other mental impairments that interfere with a normal lifestyle.

Dr.

Darrel Regier, director of the research division of the American Psychiatric Association, said the head-to-head drug comparisons are "a major step forward" that will help doctors make a choice for a second drug to try.

Doctors have to consider both effectiveness and side effects of the various drugs in deciding what's best for each patient, he said.

In fact, McEvoy said if a patient had gotten inadequate respo...

Eli Lilly "peer perform"

...Eli Lilly | detailed quote - chart - all headlines - add to watchlist previous 03/28/06 Eli Lilly's Shares Tumble On Two Downgrades 03/28/06 Eli Lilly downgraded to "underperform" Friedman,Billings,Ramsey &Co 03/28/06 Merrill Lynch, Friedman Billings Downgrade Lilly >LLY Copyright © 2002 - 2006 newratings.com, a Joint Venture of New Ratings Inc.

and aktiencheck.de AG Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using Standard&Poor's ComStock Inc.

and others.

Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.

All content copyright newratings.com.

All rights reserved.

Republication or redistribution strictly prohibited without the prior written consent of newratings.com.

In no event shall newratings.com be held liable for this or any other content, or for any actions taken in reliance thereon.

newratings.com makes no warranties, either express or implied, as to the fitness of the content for any particular purpose.

...

Eli Lilly's Earnings Growth Seen Outpacing Peers

...volume trends for "In the U.S., we are looking for two forces to stabilize the brand: a $700 million charge to eliminate 75% of the 8,000 -% String xsl=(String) application.getAttribute(com.forbes.cms.Constants.XSL_REP_KEY)+"/story_body_html_trans.xsl"; final TransformerFactory tFactory = TransformerFactory.newInstance(); final Transformer transformer = tFactory.newTransformer(new StreamSource(xsl)); final ByteArrayOutputStream bao = new ByteArrayOutpu...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Medicine   Health and Fitness